Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 10
2005 6
2006 9
2007 8
2008 8
2009 2
2010 6
2011 13
2012 18
2013 19
2014 15
2015 20
2016 18
2017 13
2018 14
2019 2
2020 3
2021 10
2022 11
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
Rao SV, Kirsch B, Bhatt DL, Budaj A, Coppolecchia R, Eikelboom J, James SK, Jones WS, Merkely B, Keller L, Hermanides RS, Campo G, Ferreiro JL, Shibasaki T, Mundl H, Alexander JH; PACIFIC AMI Investigators. Rao SV, et al. Circulation. 2022 Oct 18;146(16):1196-1206. doi: 10.1161/CIRCULATIONAHA.122.061612. Epub 2022 Aug 27. Circulation. 2022. PMID: 36030390 Clinical Trial.
Regulatory Non-coding RNAs in Atherosclerosis.
Schober A, Maleki SS, Nazari-Jahantigh M. Schober A, et al. Handb Exp Pharmacol. 2022;270:463-492. doi: 10.1007/164_2020_423. Handb Exp Pharmacol. 2022. PMID: 33454857 Review.
Regulatory Non-coding RNAs in Atherosclerosis.
Schober A, Maleki SS, Nazari-Jahantigh M. Schober A, et al. 2021 Jan 17. In: von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet]. Cham (CH): Springer; 2022. 2021 Jan 17. In: von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet]. Cham (CH): Springer; 2022. PMID: 36122128 Free Books & Documents. Review.
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice.
Cimen I, Natarelli L, Abedi Kichi Z, Henderson JM, Farina FM, Briem E, Aslani M, Megens RTA, Jansen Y, Mann-Fallenbuchel E, Gencer S, Duchêne J, Nazari-Jahantigh M, van der Vorst EPC, Enard W, Döring Y, Schober A, Santovito D, Weber C. Cimen I, et al. Among authors: schober a. Sci Transl Med. 2023 Nov;15(720):eadf3357. doi: 10.1126/scitranslmed.adf3357. Epub 2023 Nov 1. Sci Transl Med. 2023. PMID: 37910599
Mechanisms of MicroRNAs in Atherosclerosis.
Schober A, Weber C. Schober A, et al. Annu Rev Pathol. 2016 May 23;11:583-616. doi: 10.1146/annurev-pathol-012615-044135. Annu Rev Pathol. 2016. PMID: 27193456 Review.
The future of the patient-specific Body-on-a-chip.
Williamson A, Singh S, Fernekorn U, Schober A. Williamson A, et al. Among authors: schober a. Lab Chip. 2013 Sep 21;13(18):3471-80. doi: 10.1039/c3lc50237f. Lab Chip. 2013. PMID: 23685915 Review.
Chemokines and microRNAs in atherosclerosis.
Hartmann P, Schober A, Weber C. Hartmann P, et al. Among authors: schober a. Cell Mol Life Sci. 2015 Sep;72(17):3253-66. doi: 10.1007/s00018-015-1925-z. Epub 2015 May 23. Cell Mol Life Sci. 2015. PMID: 26001902 Free PMC article. Review.
MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions.
Schober A, Blay RM, Saboor Maleki S, Zahedi F, Winklmaier AE, Kakar MY, Baatsch IM, Zhu M, Geißler C, Fusco AE, Eberlein A, Li N, Megens RTA, Banafsche R, Kumbrink J, Weber C, Nazari-Jahantigh M. Schober A, et al. Circulation. 2021 Sep 28;144(13):1059-1073. doi: 10.1161/CIRCULATIONAHA.120.051614. Epub 2021 Jul 8. Circulation. 2021. PMID: 34233454 Free article.
The Year of miR-223: How Platelets Can Kill Cardiomyocytes.
Zhou Y, Schober A. Zhou Y, et al. Among authors: schober a. Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):231-233. doi: 10.1161/ATVBAHA.122.318671. Epub 2022 Dec 29. Arterioscler Thromb Vasc Biol. 2023. PMID: 36579642 Free article. No abstract available.
190 results